M&A Deal Summary |
|
---|---|
Date | 2011-07-12 |
Target | Kendle International |
Sector | Life Science |
Buyer(s) | Syneos Health |
Deal Type | Going Private |
Deal Value | 232M USD |
Advisor(s) | J.P. Morgan Securities (Financial) Keating Muething & Klekamp (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2010 |
Sector | Life Science |
Revenue | 4.4B USD (2020) |
Syneos Health is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. Syneos Health translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. Syneos Health was founded in 2010 and is based in Morrisville, North Carolina.
DEAL STATS | # |
---|---|
Overall | 1 of 7 |
Sector (Life Science) | 1 of 3 |
Type (Going Private) | 1 of 1 |
State (Ohio) | 1 of 1 |
Country (United States) | 1 of 5 |
Year (2011) | 1 of 1 |
Size (of disclosed) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-05-10 |
inVentiv Health
Burlington, Massachusetts, United States inVentiv Health, Inc. is a provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv offers convergent services that deliver extraordinary outcomes to clients whose goal is improving human life. |
Buy | $4.6B |